Ignite Creation Date:
2024-05-06 @ 8:15 PM
Last Modification Date:
2024-10-26 @ 3:24 PM
Study NCT ID:
NCT06317818
Status:
RECRUITING
Last Update Posted:
2024-03-19
First Post:
2024-02-08
Brief Title:
Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohns Disease
Sponsor:
Centre Hospitalier Universitaire de Liege
Organization:
Centre Hospitalier Universitaire de Liege
Study Overview
Official Title:
Is Local Injection of Mesenchymal Stem Cells After Endoscopic Dilation Safe and Does it Improve the Outcome of Intestinal Stricture in Patients With Crohns Disease
Status:
RECRUITING
Status Verified Date:
2024-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is an exploratory phase II study to evaluate the impact of these Mesenchymal Stem Cells MSCs on strictures in Crohns disease patients with symptomatic intestinal stricture eligible to endoscopic dilatation The impact of combined treatment by endoscopic dilation and local injection of MSCs will be compared with that of a control group
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None